Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death

The purpose of this study was to evaluate predictors of appropriate therapy in patients with implantable cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death. A retrospective cohort of 321 patients with systolic heart failure undergoing ICD placement for primary prevention of sudden cardiac death was queried with a mean follow-up period of 2.6 years. Appropriate ICD ...

Comparison of the effect of training by video and group discussion on the level of stress, anxiety, depression and self-efficacy of patients undergoing pacemaker and cardiac implantation defibrillator

Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.

The Multicenter Automatic Defibrillator Implantation Trial (MADIT) II and Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) prospectively tested the hypothesis that implantable cardioverter-defibrillators (ICDs) could reduce mortality in patients at increased risk for sudden death from ventricular tachycardia (VT) or ventricular fibrillation (VF).1,2 These trials, which demonstrated 5% to ...

Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.

BACKGROUND Prophylactic implantable cardioverter defibrillator (ICD) therapy prevents sudden cardiac death (SCD) among young adults with cardiogenetic conditions, but might reduce quality of life (QoL) due to potential device complications, ongoing medical appointments, and lifestyle restrictions. We investigated QoL in the first year after ICD implantation for the primary prevention of SCD and...

Sudden cardiac death and implantable cardioverter-defibrillators.

Sudden cardiac death is a major public health problem, affecting 500,000 patients in the United States annually. An implantable cardioverter-defibrillator (ICD) can terminate malignant ventricular arrhythmias and has been shown to improve survival in high-risk populations. Although sudden cardiac death is a heterogeneous condition, left ventricular ejection fraction of 35 percent or less remain...